Landmark Publication on Vitamin C for COVID-19

From The Epoch Times.com (Jan. 17, 2021):

Regardless of what the mainstream media wants you to think, many are starting to realize that vitamin C (ascorbic acid) and vitamin D both have an enormous amount of research showing they provide important immune function enhancements, and that your immune function is your frontline defense against all illness, including COVID-19.

The following was reported in the paper "Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect Against Viral Infections," published April 23, 2020:

"The role nutrition plays in supporting the immune system is well-established. A wealth of mechanistic and clinical data show that vitamins, including vitamins A, B6, B12, C, D, E, and folate; trace elements, including zinc, iron, selenium, magnesium, and copper; and the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid play important and complementary roles in supporting the immune system."

“Inadequate intake and status of these nutrients are widespread, leading to a decrease in resistance to infections and as a consequence an increase in disease burden."

High-Dose Vitamin C Acts as Antiviral Drug

As explained by Dr. Andrew Saul, editor-in-chief of the Orthomolecular Medicine News Service, at extremely high doses, vitamin C actually acts as an antiviral drug, effectively inactivating viruses.

His Tokyo presentation, "Orthomolecular Medicine and Coronavirus Disease: Historical Basis for Nutritional Treatment," highlights the fact that when used as a treatment, high doses of vitamin C—often 1,000 times more than the U.S. Recommended Dietary Allowance (RDA)—are needed.

It's a cornerstone of medical science that dose affects treatment outcome, but this premise isn't accepted when it comes to vitamin therapy the way it is with drug therapy. Most vitamin C research has used inadequate, low doses, which don't lead to clinical results.

"The medical literature has ignored over 80 years of laboratory and clinical studies on high-dose ascorbate therapy," Saul notes, adding that while it's widely accepted that vitamin C is beneficial in fighting illness, controversy exists over to what extent.

"Moderate quantities provide effective prevention," he says. "Large quantities are therapeutic."

Landmark Paper Puts Vitamin C on COVID-19 Treatment Map

While health authorities and mainstream media have ignored, if not outright opposed, the use of vitamin C and other supplements in the treatment of COVID-19, citing lack of clinical evidence, we now have a landmark review recommending the use of vitamin C as an adjunctive therapy for respiratory infections, sepsis, and COVID-19.

The review was published Dec. 7, 2020, in the journal Nutrients. It was co-written by Dr. Paul Marik who, in 2017, developed a groundbreaking vitamin C-based treatment for sepsis. Marik is now heading up the Front Line COVID-19 Critical Care Alliance, which has developed a highly successful treatment for COVID-19.

The COVID-19 protocol was initially dubbed MATH+ (an acronym based on the key components of the treatment), but after several tweaks and updates, the prophylaxis and early outpatient treatment protocol is now known as I-MASK+ while the hospital treatment has been renamed I-MATH+, due to the addition of the drug Ivermectin. Vitamin C remains a central component of the treatment.

The two protocols are available for download on the FLCCC Alliance website in multiple languages. The clinical and scientific rationale for the I-MATH+ hospital protocol has also been peer-reviewed and was published in the Journal of Intensive Care Medicine in mid-December 2020.

As explained in the Nutrients review abstract:

"There are limited proven therapies for COVID-19. Vitamin C's antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19.

“This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19.

“The evidence to date indicates that oral vitamin C (2-8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6-24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections ...

“Given the favorable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients' vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalized persons with COVID-19." [read more]